Oxcarbazepine
Pricing Report NDC 27241-304-01

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The current wholesale acquisition cost for Oxcarbazepine (NDC 27241-304-01) is $3.69847 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jun 17, 2026.

As a provided by Ajanta Pharma Usa Inc., this medication is distributed in a 100 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$3.69847
Per EA

Effective Date
Jun 17, 2026
Billable Units
100 EA
Estimated Package Price
$369.85
Data Status
As of Jul 08, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2024, the NADAC wholesale price for (NDC ) has moved within a range of $3.69847 to $6.75543 per EA. Over this 1 year and 5 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$3.6985 - $6.7554
Market Volatility
82.65% Variance
Latest Trend
14.71%
Date Unit Price Unit Source Method Rate
Jun 17, 2026 $3.69847 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $4.33645 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $4.50806 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $4.55072 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $4.59454 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $4.98085 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $5.26528 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $5.53108 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $5.89173 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2025 $6.26153 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2025 $6.65781 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2025 $6.71431 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2025 $6.75543 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2025 $6.59599 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2025 $6.53342 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2025 $6.40781 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2025 $6.31473 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2025 $6.27926 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2024 $6.27016 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026